Lv510
1390 积分 2025-09-16 加入
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
29天前
已完结
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
29天前
已完结
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
29天前
已完结
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
29天前
已完结
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
29天前
已完结
Identification of neoantigens for individualized therapeutic cancer vaccines
29天前
已完结
Exploiting the Mutanome for Tumor Vaccination
29天前
已完结
Identification of neoantigen-reactive tumor-infiltrating lymphocytes in primary bladder cancer
29天前
已完结
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
29天前
已完结
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
29天前
已完结
皖公网安备34019202002308
